European Cardiac Biomarker Market Size, Share and Forecast 2019-2025
The European cardiac biomarker market is estimated to grow significantly at a CAGR of around 7.1% during the forecast period. The cardiac biomarker market has a significant scope in the European region due to growing heart related diseases such as CVD, CHD, and stroke. Europe has the highest rates for CVD, CHD and other heart diseases which create a huge demand for diagnosis of cardiac diseases. Europe has a quality healthcare system and adopts the latest cardiology devices and technology to treat heart patients. Europe has a huge economic burden of heart related disease such as CVD, CHD, stroke and other heart diseases. Cardiac biomarkers can be used in the quick diagnosis of cardiac disease. Therefore, the rising incidence of CVD is expected to increase the demand for a cardiac biomarker in the region, which would prevail in the market.
To Request a Sample of our Report on European Cardiac Biomarker Market: https://www.omrglobal.com/request-sample/european-cardiac-biomarker-market
The market is segmented on the basis
of type, application, and location of testing. Based on type, the market is
segregated into Creatine kinase (CK-MB), Troponins (T, I), Myoglobin,
Natriuretic peptides (BNP & NT-PROBNP), Ischemia modified albumin and
Others. The troponin is anticipated to be the fastest growing and has a
considerable market share in the European cardiac biomarker market due to easy
and high sensitivity that results in the high adoption of the test. Based on
Application, the market is segmented into myocardial infraction, congestive
heart failure, acute coronary syndrome, atherosclerosis, and others. On the
basis of the location of testing, the market is classified into laboratory
testing and point of care testing.
A full
Report of European Cardiac Biomarker Market is Available at: https://www.omrglobal.com/industry-reports/european-cardiac-biomarker-market
European Cardiac Biomarker Market
Segmentation
·
Creatine kinase (CK-MB)
·
Troponins(T,I)
·
Myoglobin
·
Natriuretic peptides (BNP & NT-PROBNP)
·
Ischemia modified albumin
·
Others
By Application
·
Myocardial infraction
·
Congestive heart failure
·
Acute coronary syndrome
·
Atherosclerosis
·
Others
By Location of
Testing
·
Laboratory testing
·
Point of care testing
Regional
Analysis
·
UK
·
Germany
·
France
·
Italy
·
Spain
Rest of Europe
Company
Profiles
·
Abbott Laboratories
·
BioMérieux S.A.
·
Cisbio Bioassays SAS
·
Danaher Corp.
·
F. Hoffmann-La Roche AG
·
HyTest Ltd
·
Merck KGaA
·
Randox Laboratories Ltd.
·
Siemens Healthcare GmbH
·
Thermo Fisher Scientific Inc.
Reasons for Buying from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More Customized Data, Request for
Report Customization @ https://www.omrglobal.com/report-customization/european-cardiac-biomarker-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
For
More Information, Visit Orion Market Research
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment